Therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital are just a few of the trending topics of discussion at the BIO International Convention. LBG Partners …
The record number of gene, gene-modified cell therapies since last year and the recent approval of Gamida Cell’s Omisirge off-the-shelf allogeneic therapy raises an important question: How are other advanced …
Quality oversight, regulatory perspective, and risk management in the changing vendor quality landscape are key topics of discussion at the FDA-NJPQCA Conference on May 23 in Kenilworth, New Jersey. The theme …
Co-authored by Thijs Beuming, Ph.D., “Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures” was recently published in the Journal of …
